| Value | ₹274.5 Cr |
|---|---|
| Execution period | 5 years |
| approved annual mining capacity (new block) | 1.038 MTPA |
NSE filing, NSE: MONOLITH. Summary written from the filing by ALFA Finder's alert engine.
Monolithisch India Ltd: key numbers
- Share price
- ₹1,470.00
- Market cap
- ₹3,195 Cr
- Revenue (annual)
- ₹135.3 Cr
- Net profit (annual)
- ₹23.03 Cr
- P/E (TTM)
- 138.8×Sector 51.0×
- Promoter holding
- 74.57%+0.30% QoQ
- FII holding
- 1.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Monolithisch India Ltd
All →Monolithisch India Product Launch
Monolithisch India launched its mobile application, an enterprise refractory portal for purchase orders, dispatch and vehicle tracking. The app is live on Google Play, with iOS release to follow.
Monolithisch India Other Announcement
No deviation from IPO proceeds objects reported for the half year ended September 30, 2026. Routine compliance filing; no new financial event.
Monolithisch India Management Change
Monolithisch India's internal auditor Aanchal Garodia resigned effective November 3, 2026, citing personal reasons. Archie Priya was appointed internal auditor effective November 10, 2026.
Monolithisch India Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹53.6 Cr (+88.2% YoY), EBITDA ₹15.8 Cr (29.5% margin), PAT ₹11.2 Cr (+145.1%), driven by SGB Limited premiumisation and 5.76 lakh MTPA scale.
Monolithisch India Results Update
Monolithisch India reported record Q2 FY27 revenue of ₹53.59 crore, up 88.2%. Its greenfield facility began commercial production on October 10, 2026.
Monolithisch India Q2 FY27 Results: Net Profit ₹11.2 Cr, Up 143.5% YoY
Monolithisch India Ltd reported revenue from operations of ₹53.6 Cr (+88.1% YoY) and net profit of ₹11.2 Cr (+143.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹11.2 Cr · +143.5% YoY
Other acquisition announcements
All →Piramal Pharma Acquisition
Piramal Pharma exercised a call option to acquire the remaining 26% stake in subsidiary Yapan Bio. Final consideration and transfer date are yet to be finalised.
Advent Hotels International Acquisition Worth ₹5.38 Cr
Advent Hotels acquired 50% control of Advent Convention and Hotels International Pvt Ltd for Rs.5.38 Crore cash. The target will develop a Mumbai commercial project.
- Value
- ₹5.38 Cr
- Execution
- Indicative completion date stated as 17-11-2026
Phoenix Mills Acquisition Worth ₹373.9 Cr
Phoenix Mills' stake in subsidiary ISMDPL rose to 71.23% after ISMDPL bought back CPP Investments' shares. Consideration was Rs.373.88 Crore, paid on 18 November 2026.
- Value
- ₹373.9 Cr
AYM Syntex Acquisition
NCLT Mumbai sanctioned the amalgamation of Mandawewala Enterprises into AYM Syntex, effective on sanction. The formal order is awaited and will be disclosed when received.
ACCEL Acquisition Worth ₹3.01 Cr
Accel will buy 2,98,399 Secureinteli shares at ₹101 each, lifting its stake to 84.10%. Secureinteli becomes a subsidiary, a deal worth about ₹3.01 Crore.
- Value
- ₹3.01 Cr
Prestige Estates Projects Acquisition Worth ₹2.69 Cr
Prestige's subsidiary acquired 50% of Advent Convention for ₹2.69 Crore. The target holds 21,978 sq. m land in Mumbai for a ₹4,500 Crore commercial project.
- Value
- ₹2.69 Cr
- leasable area
- 1500000 sq. ft.